PDL BioPharma posts third quarter financial results
Incline Village-based PDL BioPharma, Inc. reported total revenues of $62.7 million in the third quarter and $252 million for the nine months ending Sept. 30.
Operating expenses for the third quarter were $30.1 million, compared to $21 million from 2016. Operating expenses were $88.1 million for the nine months ended Sept. 30, compared to $40.7 million in the same period 2016.
Nevada OSHA officials are at the point where they are now conducting follow-up visits at locations where noncompliance was first observed. The maximum penalty that can be assessed is $134,940.